SCHEMBL29979719

SCHEMBL29979719

CN1CCN(c2ccccc2NS(=O)(=O)c2ccc(S(C)(=O)=O)cc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.60
MCOLN3 Q8TDD5 3/20 0.60
MCOLN2 Q8IZK6 1/20 0.60
MCOLN1 Q9GZU1 1/20 0.60
PKM P14618 3/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
HTR6 P50406 3/20 0.49
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 2/20 0.47
APAF1 O14727 1/20 0.47
MITF O75030 1/20 0.47
RAD52 P43351 1/20 0.46
GAA P10253 2/20 0.46
PTGS2 P35354 1/20 0.46
BRD4 O60885 1/20 0.46
CREBBP Q92793 1/20 0.46
CECR2 Q9BXF3 1/20 0.46
BRD9 Q9H8M2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043627 1.00 TSHR (0.60) TSHRMCOLN3MCOLN2MCOLN1PKM
SCHEMBL14355853 0.90 MCOLN3 (0.71) TSHRMCOLN3MCOLN2MCOLN1PKM
SCHEMBL29979203 0.88 TSHR (0.60) TSHRMCOLN3MCOLN2MCOLN1PKM
SCHEMBL23043661 0.88 TSHR (0.60) TSHRMCOLN3MCOLN2MCOLN1PKM
SCHEMBL29979148 0.88 MCOLN3 (0.76) MCOLN3MCOLN2MCOLN1PKML3MBTL1
SCHEMBL23043616 0.88 MCOLN3 (0.76) MCOLN3MCOLN2MCOLN1PKML3MBTL1
SCHEMBL23057205 0.86 TSHR (0.57) TSHRMCOLN3MCOLN2MCOLN1PKM
SCHEMBL23043582 0.86 TSHR (0.57) TSHRMCOLN3MCOLN2MCOLN1PKM
SCHEMBL29978797 0.86 TSHR (0.57) TSHRMCOLN3MCOLN2MCOLN1PKM
SCHEMBL23043578 0.85 MCOLN3 (0.57) TSHRMCOLN3MCOLN2MCOLN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 TSHR 2343/4885MCOLN3 3/4885MCOLN2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.